Brief: EyeGate Is Now Kiora Pharmaceuticals
08/11/2021 12:50
Nov 8 (Reuters) - EyeGate Pharmaceuticals Inc KPRX.O
* EYEGATE IS NOW KIORA PHARMACEUTICALS; PROVIDES UPDATE ON
COMPANY’S SHARPENED CLINICAL DEVELOPMENT STRATEGY
* KIORA PHARMACEUTICALS INC - KIORA WILL TRADE ON NASDAQ
CAPITAL
MARKET UNDER TICKER SYMBOL "KPRX"
Source text for Eikon: ID:nGNX541wgj
Further company coverage: KPRX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing